Journal article · 2026
Pharmacogenetics and Pharmacogenomics as Enabling Technologies for Precision Drug Development and Personalized Therapy
Current Drug Discovery Technologies, 23 · Published 30 July 2026 · DOI 10.2174/0115701638494182260723063335
In brief
“Pharmacogenetics and Pharmacogenomics as Enabling Technologies for Precision Drug Development and Personalized Therapy” is a 2026 journal article by Nikolet Pavlova and 3 co-authors, published in Current Drug Discovery Technologies. OpenAlex counts 0 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- Authors
- 4
Abstract
Differences among individuals in susceptibility to adverse drug reactions are strongly influenced by genetic variation affecting drug metabolism, transport, immune response, and pharmacodynamics pathways, presenting both challenges and opportunities for drug discovery and development. Genetic and genomic variation can modify pharmacokinetics, pharmacodynamics, immunemediated toxicity, treatment resistance, and biomarker-defined therapeutic benefit, making pharmacogenetics and pharmacogenomics central… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Pavlova, N., Kaloudas, D., Traykovska, M., & nat., R. P. D. R. (2026). Pharmacogenetics and Pharmacogenomics as Enabling Technologies for Precision Drug Development and Personalized Therapy. Current Drug Discovery Technologies, 23. https://doi.org/10.2174/0115701638494182260723063335
MLA 9
Pavlova, Nikolet, et al. “Pharmacogenetics and Pharmacogenomics as Enabling Technologies for Precision Drug Development and Personalized Therapy.” Current Drug Discovery Technologies, vol. 23, 2026. https://doi.org/10.2174/0115701638494182260723063335.
Chicago
Pavlova, Nikolet, Dimitrios Kaloudas, Martina Traykovska, and Robert Penchovsky, Dr. rer. nat. 2026. “Pharmacogenetics and Pharmacogenomics as Enabling Technologies for Precision Drug Development and Personalized Therapy.” Current Drug Discovery Technologies 23. https://doi.org/10.2174/0115701638494182260723063335.
Harvard
Pavlova, N. et al. (2026) ‘Pharmacogenetics and Pharmacogenomics as Enabling Technologies for Precision Drug Development and Personalized Therapy’, Current Drug Discovery Technologies, 23. doi:10.2174/0115701638494182260723063335.
IEEE
N. Pavlova, D. Kaloudas, M. Traykovska, and R. P. D. R. nat., “Pharmacogenetics and Pharmacogenomics as Enabling Technologies for Precision Drug Development and Personalized Therapy,” Current Drug Discovery Technologies, vol. 23, 2026, doi: 10.2174/0115701638494182260723063335.
BibTeX
@article{pavlova2026pharmacogenetics,
title = {{Pharmacogenetics and Pharmacogenomics as Enabling Technologies for Precision Drug Development and Personalized Therapy}},
author = {Pavlova, Nikolet and Kaloudas, Dimitrios and Traykovska, Martina and nat., Robert Penchovsky, Dr. rer.},
journal = {Current Drug Discovery Technologies},
year = {2026},
volume = {23},
doi = {10.2174/0115701638494182260723063335},
url = {https://doi.org/10.2174/0115701638494182260723063335}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenetics
- pharmacogenomics
- precision medicine
- personalized treatment
- adverse drug reactions
- drug metabolism
- pharmacokinetics
- pharmacodynamics
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Pavlova, N., Kaloudas, D., Traykovska, M., & nat., R. P. D. R. (2026). Pharmacogenetics and Pharmacogenomics as Enabling Technologies for Precision Drug Development and Personalized Therapy. Current Drug Discovery Technologies, 23. https://doi.org/10.2174/0115701638494182260723063335
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Nikolet Pavlova, Dimitrios Kaloudas, Martina Traykovska, Robert Penchovsky, Dr. rer. nat..
What is the DOI of this paper?
10.2174/0115701638494182260723063335, permanently at https://doi.org/10.2174/0115701638494182260723063335. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.